CDMO Service
Product Description
Shilpa Biologicals Ltd
-
Country/Region:India
-
On CPHI since:2025
Shilpa Biologicals Ltd
-
Country/Region:India
-
On CPHI since:2025
More Products from Shilpa Biologicals Ltd (2)
-
Product Biosimilar Products
Nivolumab Pembrolizumab Adalimumab Aflibercept Dupilumab Daratumumab Trastuzumab Emtansine (ADC) Trastuzumab Deruxtecan (ADC) -
Product recombinant albumin
Exploring Recombinant Albumin for Advanced Formulation & Manufacturing? Shilpa's GMP-grade recombinant human albumin (rHA) is designed to enhance process consistency, formulation robustness, and regulatory reliability—particularly for complex injectable and biologic products

